DOCS vs TWST
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
DOCS · Doximity$32.51 ▼ 2.02%
TWST · Twist Bioscience$120.79 ▲ 0.15%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- DOCS -38.1%
- TWST +290.1%
Head to head
| Metric | DOCS | TWST |
|---|---|---|
| Price | $32.51 | $120.79 |
| Change today | ▼ 2.02% | ▲ 0.15% |
| Market cap | $5.80B | $8.01B |
| Return, 3 months | +26.8% | -3.3% |
| Return, year to date | -26.6% | +280.8% |
| Return, 1 year | -40.1% | +299.0% |
| P/E (TTM) | 45.2 | -54.2 |
| P/B | 6.2 | 18.0 |
| P/E percentile vs own 5y | 27th | 5th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +7.3% | +23.2% |
| Net profit growth (YoY) | -54.4% | -271.9% |
| Gross margin | 88.1% | 52.0% |
| Operating margin | 29.6% | -31.9% |
| Net margin | 25.5% | -31.7% |
| Return on equity | 17.2% | -29.6% |
| Analyst target vs. price | -2.5% | +45.8% |
| Analyst buy share | 44% | 83% |
| RSI (14) | 55 | 39 |
| 30-day volatility | 46.8% | 124.5% |
| Max drawdown, 1 year | -73.7% | -41.2% |
| Trend read | Leaning bullish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- TWST is the largest of the group by market value.
- TWST has returned the most over the past year.
- TWST carries the lowest trailing P/E.
- TWST is growing revenue fastest.
- DOCS keeps the most profit per dollar of sales.
- DOCS has been the calmest stock over the last 30 days.